A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
Researchers at Cincinnati Children’s Hospital Medical Center, in collaboration with Roche, have developed a next-generation ...
News-Medical.Net on MSN
Microarray platform could help predict immune‐mediated drug‐induced liver injury
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In ...
The global human liver model market was valued at USD 1.19 billion in 2023 and is projected to expand at a robust CAGR of 13.8% from 2024 to 2030, culminating in a market size of USD 3.19 billion by ...
The Brighterside of News on MSN
Simple blood test can predict risk of severe liver disease years in advance
In a large laboratory system in Europe, the set of tests needed ... or sticking with follow-up care—before serious problems arise. The CORE model could help primary care doctors diagnose liver disease ...
News-Medical.Net on MSN
UCSF team uncovers breakthrough immunotherapy for colon cancer liver metastases
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In ...
A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback